SPINT2 Antilichaam - C-terminalgebied: FITC (ARP59165 P050-FITC)

Serine peptidase inhibitor, Kunitz type, 2

PB, Kop, HAI2, DIAR3, HAI-2

10653

O43291

NP_066925

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the C terminal region of human SPINT2

HAI-2 (SPINT2) is a candidate tumour suppressor gene that is frequently hypermethylated and underexpressed in human HCCs, and the KD-1 domain of HAI-2 is the key region responsible for its anti-invasive function. It is also implicated in human cervical cancer.

TUBG1; APP; UBC; SUMO4; HGFAC; ITIH3; CTSB; ITIH2

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

SPINT2 is supported by BioGPS gene expression data to be expressed in OVCAR3

0.5 mg/ml

Cow: 100%; Dog: 100%; Guinea Pig: 86%; Horse: 92%; Human: 100%; Mouse: 86%; Rabbit: 86%; Rat: 93%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

28kDa

Wet Ice

252

SPINT2

SPINT2

Rabbit

Kunitz-type protease inhibitor 2

NM_021102

LAGLFVMVLILFLGASMVYLIRVARRNQERALRTVWSSGDDKEQLVKNTY